Syros Pharmaceuticals (SYRS) Event Aug. 09, 2022, 00:00 UTC (76% Positive) SYROS PHARMACEUTICALS, INC. (SYRS) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 6:29 p.m. 🏢 Syros Pharmaceuticals (SYRS) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-09 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-75.40M $-84.00M $8.60M +10.24% 📉 Total Assets $182.94M $126.23M $56.70M +44.92% 📈 Stockholders' Equity $31.02M $-523.21M $554.23M +105.93% 📈 Operating Income/Loss $-47.09M $-60.42M $13.34M +22.07% 📉 R&D Expense $45.81M $58.27M $-12.46M -21.38% 📈 Earningspersharebasic $-0.59 $-0.94 $0.35 +37.23% 📈 Earningspersharediluted $-0.59 $-0.94 $0.35 +37.23% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Syros Pharmaceuticals (SYRS) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document